| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 17.63 | 7.4% | 20.5% |
| Total Income | 17.63 | 7.4% | 20.5% |
| Expenditure | 24.44 | 53.8% | 33.4% |
| PBT | 8.85 | 133.2% | |
| Net Profit | 5.85 | 62.2% | 145.4% |
| OPM | -38.63% | ||
| NPM | 33.18% | 61.17pp | 121.14pp |
| EPS | 0.13 | 74.0% | 117.1% |
Fortress Biotech Reports Q3 2025 Results
04 May 2026 · 4 May, 7:09 am
Summary
Fortress Biotech, Inc. issued a press release on November 14, 2025, to announce its financial results for the quarter ended September 30, 2025. The press release also provided a corporate update. The press release is furnished as Exhibit 99.1 to the report. The information contained within the Form 8-K, including the exhibit, is furnished and not filed for the purposes of Section 18 of the Securities Exchange Act of 1934.
Key Highlights
- 1
Fortress Biotech, Inc. announced its financial results for the quarter ended September 30, 2025.
- 2
A press release was issued to provide a corporate update and announce the financial results.
- 3
The press release is dated November 14, 2025.
- 4
The information is furnished as Exhibit 99.1 to the report.
Informational and educational content only. Not investment advice.